Form 4: LivaNova Director Todd Schermerhorn Trades Shares

LivaNova PLC director Todd C. Schermerhorn reported transactions involving ordinary shares and restricted stock units on June 15, 2026.

Summary

• Todd C. Schermerhorn, a Director at LivaNova PLC, engaged in several transactions on June 15, 2026.
• He acquired 4,042 ordinary shares upon the settlement of vested restricted stock units (RSUs) with a transaction price of $0.
• These RSUs were granted under the 2025 Director Incentive Award Plan and vested on June 15, 2026.
• Additionally, 486 ordinary shares were disposed of to satisfy tax liabilities, with a transaction price of $79.7.
• Schermerhorn also received a grant of 2,383 RSUs under the 2025 Plan, which are set to vest on June 15, 2027, contingent upon continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine equity award settlements and grants for a director, with a minor disposal for tax purposes, rather than significant strategic or financial events.

Positives

• Director acquired 4,042 ordinary shares through vested RSUs, indicating potential alignment with company performance.
• The settlement of RSUs at $0 suggests a benefit to the director from prior equity awards.
• Grant of 2,383 new RSUs with a future vesting date (June 15, 2027) signals continued incentive for the director.

Negatives

• 486 ordinary shares were disposed of to cover tax liabilities, representing a reduction in direct shareholding.

Risks

• The disposal of shares to cover tax liabilities, while common, reduces the director's direct ownership stake.
• Future vesting of RSUs is contingent on continued service, implying a risk of forfeiture if the director departs before the vesting date.

Future Outlook

The filing indicates that 2,383 restricted stock units granted under the 2025 Plan are scheduled to vest on June 15, 2027, subject to continued service.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The activity reported by Director Todd C. Schermerhorn, including the settlement of vested RSUs and the grant of new ones, is typical for executive compensation and incentive structures within the medical technology sector.

Stakeholder Impact

• Shareholders: The transactions reflect standard executive compensation practices and do not immediately suggest a change in the director's beneficial ownership that would significantly impact share price.
• Employees: The 2025 Director Incentive Award Plan, under which these RSUs were granted, may serve as a model for other employee incentive programs.
• Management: The transactions indicate continued incentive alignment for the director with the company's performance and long-term objectives.

Next Steps

• Vesting of 2,383 RSUs on June 15, 2027, contingent on continued service.

Key Dates

Keywords

LivaNova PLC, Form 4, SEC Filing, Insider Trading, Director Transactions, Restricted Stock Units, Ordinary Shares, Equity Awards, Todd C. Schermerhorn, LIVN